DNMT1 and hepatocellular carcinoma: discovered that in sorafenib‐resistant HCC cells, programmed death‐ligand 1 (PD‐L1) activates the expression of DNMT1 by activating the Signal Transducer And Activator Of Transcription 3 (STAT3).